Acute Myeloid Leukemia Version 2.2024
Biliary Tract Cancers Version 1.2024
Bladder Cancer Version 3.2024
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2024
Hepatocellular Carcinoma Version 1.2024
Melanoma: Cutaneous Version 2.2024
Non-Small Cell Lung Cancer Version 4.2024
Pediatric Acute Lymphoblastic Leukemia Version 5.2024
Pediatric Aggressive Mature B-Cell Lymphomas Version 1.2024
T-Cell Lymphomas Version 3.2024
Vaginal Cancer Version 1.2025
NCCN Guidelines with Evidence Blocks - Acute Myeloid Leukemia Version 2.2024
NCCN Guidelines with Evidence Blocks - Bladder Cancer Version 3.2024
NCCN Guidelines with Evidence Blocks - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2024
NCCN Guidelines with Evidence Blocks - Melanoma: Cutaneous Version 2.2024
NCCN Guidelines with Evidence Blocks - Non-Small Cell Lung Cancer Version 4.2024
NCCN Guidelines with Evidence Blocks - Pediatric Acute Lymphoblastic Leukemia Version 5.2024
NCCN Guidelines with Evidence Blocks - Pediatric Aggressive Mature B-Cell Lymphomas Version 1.2024
NCCN Guidelines with Evidence Blocks - T-Cell Lymphomas Version 3.2024
NCCN Guidelines with Evidence Blocks - Vaginal Cancer Version 1.2025
Breast Cancer Screening and Diagnosis Version 2.2024
Distress Management Version 2.2024
Survivorship Version 1.2024
Cancer in People with HIV Version 2.2024